Why ProQR Therapeutics's Stock Is Trading Higher Today

ProQR Therapeutics's PRQR shares are trading higher after the company announced Axiomer RNA editing licensing and research collaboration with Lilly.

ProQR Therapeutics stock has been rising Thursday, up 18.21% to a price of $8.05. The stock's volume is currently 11.70 million, which is roughly 2498.78% of its recent 30-day volume average of 468.22 thousand.

The 50-day moving average price of ProQR Therapeutics's stock was $6.09 when this article was published. The stock reached a high of $9.46 and a low of $3.4 in the past 52 weeks.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.